Parkin represses 6-hydroxydopamine-induced apoptosis via stabilizing scaffold protein p62 in PC12 cells

Abstract

Aim: Parkin has been shown to exert protective effects against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in different models of Parkinson disease. In the present study we investigated the molecular mechanisms underlying the neuroprotective action of parkin in vitro. Methods: HEK293, HeLa and PC12 cells were transfected with parkin, parkin mutants, p62 or si-p62. Protein expression and ubiquitination were assessed using immunoblot analysis. Immunoprecipitation assay was performed to identify the interaction between parkin and scaffold protein p62. PC12 and SH-SY5Y cells were treated with 6-OHDA (200 μmol/L), and cell apoptosis was detected using PI and Hoechst staining. Results: In HEK293 cells co-transfected with parkin and p62, parkin was co-immunoprecipitated with p62, and parkin overexpression increased p62 protein levels. In parkin-deficient HeLa cells, transfection with wild-type pakin, but not with ligase activity-deficient pakin mutants, significantly increased p62 levels, suggesting that parkin stabilized p62 through its E3 ligase activity. Transfection with parkin or p62 significantly repressed ERK1/2 phosphorylation in HeLa cells, but transfection with parkin did not repress ERK1/2 phosphorylation in p62-knockdown HeLa cells, suggesting that p62 was involved in parkin-induced inhibition on ERK1/2 phosphorylation. Overexpression of parkin or p62 significantly repressed 6-OHDA-induced ERK1/2 phosphorylation in PC12 cells, and parkin overexpression inhibited 6-OHDA-induced apoptosis in PC12 and SH-SY5Y cells. Conclusion: Parkin protects PC12 cells against 6-OHDA-induced apoptosis via ubiquitinating and stabilizing scaffold protein p62, and repressing ERK1/2 activation.

Autophagy promotes invadopodia formation in human ovarian cancer cells via the p62-extracellular signal-regulated kinase 1/2 pathway

“…As a result, the regulatory mechanism is a complex phenomenon. Additionally, according to other previous studies, p62 expression exerts an inhibitory effect on ERK1/2 activity (13,23,(36)(37)(38).…”

Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1

“…Immunoblotting experiments were carried out according to a method described previously (57). Briefly, cell lysates or immunoprecipitates were mixed with a proper amount of 5ϫ SDS sample loading buffer, heated at 98°C for 10 min, and centrifuged at 16,000 ϫ g for 10 min.…”

Vitamin K2 suppresses rotenone-induced microglial activation in vitro

“…Parkinson's disease (PD) is the second most common neurodegenerative disorder and is characterized by the preferential loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). Both genetic and environmental factors can cause PD [1][2][3] . Multiple cellular alterations are associated with PD pathogenesis, including the accumulation of toxic proteins [4] , oxidative stress [5] , mitochondrial dysfunction [6] and neuroinflammation [7] .…”